Esc tumor cells engineered to re-express Irf6 regained sensitivity to T cell killing upon OT-I co-culture (Fig. 5a), whereas parental cells lacking Irf6 (Irf6-/-) became resistant to OT-I cell killing (Fig. 5b). The gene discussed is IRF6; the disease is neoplasm.